Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts, Malaria Journal

This paper examines the far-reaching implications of Triple Artemisinin-Based Combination Therapy (TACT) in the global battle against malaria. Artemisinin-Based Combination Therapy (ACT) is recognized for its cost-effectiveness, lower likelihood of adverse events, and widespread acceptance by patients and healthcare providers. However, TACT introduces novel dimensions to the fight against malaria that make them a superior choice in several aspects. TACT has been demonstrated to address resistance, offer a broader spectrum of action, reduce the risk of treatment failure, and can be tailored to meet regional needs, strengthening the global effort to combat malaria. However, maximizing these benefits of TACT depends on accessibility, particularly in resource-limited regions where malaria is most prevalent. Collaborative efforts among stakeholders, sustainable pricing strategies, efficient supply chains, and public–private partnerships are essential to ensure that TACT reaches needy populations. Moreover, dispelling prevalent malaria myths through health education campaigns is critical in this endeavour. The paper underscores the significance of collaborative initiatives and partnerships among governments, international organizations, research institutions, acadaemia, pharmaceutical companies, and local communities. Together, these efforts can pave the way for the acceptance, adoption, and success of TACT, ultimately advancing the global goal of a malaria-free world.

Efficacy and resistance of different artemisinin-based combination therapies: a systematic review and network meta-analysis - ScienceDirect

Tracking resistance to artemisinin collaboration II (TRAC II)

PDF) Tools to accelerate falciparum malaria elimination in Cambodia: a meeting report

Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa - ScienceDirect

PDF) Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991–2019

Investigating the efficacy of triple artemisinin-based combination therapies (TACTs) for treating Plasmodium falciparum malaria patients using mathematical modelling

Pharmaceutics, Free Full-Text

Anopheles arabiensis continues to be the primary vector of Plasmodium falciparum after decades of malaria control in southwestern Ethiopia

Modulation of triple artemisinin-based combination therapy pharmacodynamics by Plasmodium falciparum genotype

Antimalarial Drugs and the Control and Elimination of Malaria

Funding landscape for malaria intervention commodities

PDF) Artemisinin-based combination therapy in the treatment of uncomplicated malaria: review of recent regulatory experience at the European Medicines Agency

WWARN (@WWARN) / X

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies

media.springer/w215h120/springer-static/